 | • レポートコード：GIR-107A14425 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、皮膚筋炎治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。皮膚筋炎治療薬の種類別市場規模（アバタセプト、バリシチニブ、ダラザチド、免疫グロブリン、IMO-8400、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・皮膚筋炎治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：MedImmune LLC、Neovacs SA、Novartis AG、Octapharma AG、Pfizer Inc、Eli Lilly and Company、F. Hoffmann-La Roche Ltd、Hope Pharmaceuticals Inc、Idera Pharmaceuticals Inc、KPI Therapeutics Inc、Marathon Pharmaceuticals LLC ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アバタセプト、バリシチニブ、ダラザチド、免疫グロブリン、IMO-8400、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・皮膚筋炎治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・皮膚筋炎治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・皮膚筋炎治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・皮膚筋炎治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・皮膚筋炎治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Dermatomyositis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Dermatomyositis Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Dermatomyositis Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Dermatomyositis Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Abatacept
Baricitinib
Dalazatide
Immune Globulin
IMO-8400
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Dermatomyositis Drug market are listed below:
MedImmune LLC
Neovacs SA
Novartis AG
Octapharma AG
Pfizer Inc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Hope Pharmaceuticals Inc
Idera Pharmaceuticals Inc
KPI Therapeutics Inc
Marathon Pharmaceuticals LLC
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Dermatomyositis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatomyositis Drug, with price, sales, revenue and global market share of Dermatomyositis Drug from 2019 to 2021.
Chapter 3, the Dermatomyositis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatomyositis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Dermatomyositis Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Dermatomyositis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Dermatomyositis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatomyositis Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Abatacept
1.2.3 Baricitinib
1.2.4 Dalazatide
1.2.5 Immune Globulin
1.2.6 IMO-8400
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatomyositis Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Dermatomyositis Drug Market Size & Forecast
1.4.1 Global Dermatomyositis Drug Sales in Value (2016-2026))
1.4.2 Global Dermatomyositis Drug Sales in Volume (2016-2026)
1.4.3 Global Dermatomyositis Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Dermatomyositis Drug Production Capacity Analysis
1.5.1 Global Dermatomyositis Drug Total Production Capacity (2016-2026)
1.5.2 Global Dermatomyositis Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dermatomyositis Drug Market Drivers
1.6.2 Dermatomyositis Drug Market Restraints
1.6.3 Dermatomyositis Drug Trends Analysis
2 Manufacturers Profiles
2.1 MedImmune LLC
2.1.1 MedImmune LLC Details
2.1.2 MedImmune LLC Major Business
2.1.3 MedImmune LLC Dermatomyositis Drug Product and Services
2.1.4 MedImmune LLC Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Neovacs SA
2.2.1 Neovacs SA Details
2.2.2 Neovacs SA Major Business
2.2.3 Neovacs SA Dermatomyositis Drug Product and Services
2.2.4 Neovacs SA Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Dermatomyositis Drug Product and Services
2.3.4 Novartis AG Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Octapharma AG
2.4.1 Octapharma AG Details
2.4.2 Octapharma AG Major Business
2.4.3 Octapharma AG Dermatomyositis Drug Product and Services
2.4.4 Octapharma AG Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Pfizer Inc
2.5.1 Pfizer Inc Details
2.5.2 Pfizer Inc Major Business
2.5.3 Pfizer Inc Dermatomyositis Drug Product and Services
2.5.4 Pfizer Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company Dermatomyositis Drug Product and Services
2.6.4 Eli Lilly and Company Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 F. Hoffmann-La Roche Ltd
2.7.1 F. Hoffmann-La Roche Ltd Details
2.7.2 F. Hoffmann-La Roche Ltd Major Business
2.7.3 F. Hoffmann-La Roche Ltd Dermatomyositis Drug Product and Services
2.7.4 F. Hoffmann-La Roche Ltd Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Hope Pharmaceuticals Inc
2.8.1 Hope Pharmaceuticals Inc Details
2.8.2 Hope Pharmaceuticals Inc Major Business
2.8.3 Hope Pharmaceuticals Inc Dermatomyositis Drug Product and Services
2.8.4 Hope Pharmaceuticals Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Idera Pharmaceuticals Inc
2.9.1 Idera Pharmaceuticals Inc Details
2.9.2 Idera Pharmaceuticals Inc Major Business
2.9.3 Idera Pharmaceuticals Inc Dermatomyositis Drug Product and Services
2.9.4 Idera Pharmaceuticals Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 KPI Therapeutics Inc
2.10.1 KPI Therapeutics Inc Details
2.10.2 KPI Therapeutics Inc Major Business
2.10.3 KPI Therapeutics Inc Dermatomyositis Drug Product and Services
2.10.4 KPI Therapeutics Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Marathon Pharmaceuticals LLC
2.11.1 Marathon Pharmaceuticals LLC Details
2.11.2 Marathon Pharmaceuticals LLC Major Business
2.11.3 Marathon Pharmaceuticals LLC Dermatomyositis Drug Product and Services
2.11.4 Marathon Pharmaceuticals LLC Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Dermatomyositis Drug Sales by Manufacturer
3.1 Global Dermatomyositis Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Dermatomyositis Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Dermatomyositis Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatomyositis Drug Manufacturer Market Share
3.4.2 Top 6 Dermatomyositis Drug Manufacturer Market Share
3.5 Global Dermatomyositis Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Dermatomyositis Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dermatomyositis Drug Market Size by Region
4.1.1 Global Dermatomyositis Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Dermatomyositis Drug Revenue by Region (2016-2026)
4.2 North America Dermatomyositis Drug Revenue (2016-2026)
4.3 Europe Dermatomyositis Drug Revenue (2016-2026)
4.4 Asia-Pacific Dermatomyositis Drug Revenue (2016-2026)
4.5 South America Dermatomyositis Drug Revenue (2016-2026)
4.6 Middle East and Africa Dermatomyositis Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Dermatomyositis Drug Sales in Volume by Type (2016-2026)
5.2 Global Dermatomyositis Drug Revenue by Type (2016-2026)
5.3 Global Dermatomyositis Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Dermatomyositis Drug Sales in Volume by Application (2016-2026)
6.2 Global Dermatomyositis Drug Revenue by Application (2016-2026)
6.3 Global Dermatomyositis Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Dermatomyositis Drug Sales by Type (2016-2026)
7.2 North America Dermatomyositis Drug Sales by Application (2016-2026)
7.3 North America Dermatomyositis Drug Market Size by Country
7.3.1 North America Dermatomyositis Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Dermatomyositis Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Dermatomyositis Drug Sales by Type (2016-2026)
8.2 Europe Dermatomyositis Drug Sales by Application (2016-2026)
8.3 Europe Dermatomyositis Drug Market Size by Country
8.3.1 Europe Dermatomyositis Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Dermatomyositis Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Dermatomyositis Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Dermatomyositis Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Dermatomyositis Drug Market Size by Region
9.3.1 Asia-Pacific Dermatomyositis Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Dermatomyositis Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Dermatomyositis Drug Sales by Type (2016-2026)
10.2 South America Dermatomyositis Drug Sales by Application (2016-2026)
10.3 South America Dermatomyositis Drug Market Size by Country
10.3.1 South America Dermatomyositis Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Dermatomyositis Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dermatomyositis Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Dermatomyositis Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Dermatomyositis Drug Market Size by Country
11.3.1 Middle East & Africa Dermatomyositis Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Dermatomyositis Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Dermatomyositis Drug Typical Distributors
12.3 Dermatomyositis Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Dermatomyositis Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Dermatomyositis Drug Revenue by Application, (USD Million), 2021-2026
Table 3. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 4. MedImmune LLC Major Business
Table 5. MedImmune LLC Dermatomyositis Drug Product and Services
Table 6. MedImmune LLC Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Neovacs SA Basic Information, Manufacturing Base and Competitors
Table 8. Neovacs SA Major Business
Table 9. Neovacs SA Dermatomyositis Drug Product and Services
Table 10. Neovacs SA Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 12. Novartis AG Major Business
Table 13. Novartis AG Dermatomyositis Drug Product and Services
Table 14. Novartis AG Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Octapharma AG Basic Information, Manufacturing Base and Competitors
Table 16. Octapharma AG Major Business
Table 17. Octapharma AG Dermatomyositis Drug Product and Services
Table 18. Octapharma AG Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Inc Major Business
Table 21. Pfizer Inc Dermatomyositis Drug Product and Services
Table 22. Pfizer Inc Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company Major Business
Table 25. Eli Lilly and Company Dermatomyositis Drug Product and Services
Table 26. Eli Lilly and Company Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 28. F. Hoffmann-La Roche Ltd Major Business
Table 29. F. Hoffmann-La Roche Ltd Dermatomyositis Drug Product and Services
Table 30. F. Hoffmann-La Roche Ltd Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Hope Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 32. Hope Pharmaceuticals Inc Major Business
Table 33. Hope Pharmaceuticals Inc Dermatomyositis Drug Product and Services
Table 34. Hope Pharmaceuticals Inc Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Idera Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 36. Idera Pharmaceuticals Inc Major Business
Table 37. Idera Pharmaceuticals Inc Dermatomyositis Drug Product and Services
Table 38. Idera Pharmaceuticals Inc Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. KPI Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 40. KPI Therapeutics Inc Major Business
Table 41. KPI Therapeutics Inc Dermatomyositis Drug Product and Services
Table 42. KPI Therapeutics Inc Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Marathon Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 44. Marathon Pharmaceuticals LLC Major Business
Table 45. Marathon Pharmaceuticals LLC Dermatomyositis Drug Product and Services
Table 46. Marathon Pharmaceuticals LLC Dermatomyositis Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Dermatomyositis Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 48. Global Dermatomyositis Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Dermatomyositis Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Dermatomyositis Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 51. Head Office and Dermatomyositis Drug Production Site of Key Manufacturer
Table 52. Dermatomyositis Drug New Entrant and Capacity Expansion Plans
Table 53. Dermatomyositis Drug Mergers & Acquisitions in the Past Five Years
Table 54. Global Dermatomyositis Drug Sales by Region (2016-2021e) & (K Pcs)
Table 55. Global Dermatomyositis Drug Sales by Region (2021-2026) & (K Pcs)
Table 56. Global Dermatomyositis Drug Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Dermatomyositis Drug Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Dermatomyositis Drug Sales by Type (2016-2021e) & (K Pcs)
Table 59. Global Dermatomyositis Drug Sales by Type (2021-2026) & (K Pcs)
Table 60. Global Dermatomyositis Drug Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Dermatomyositis Drug Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Dermatomyositis Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 63. Global Dermatomyositis Drug Price by Type (2021-2026) & (USD/Pcs)
Table 64. Global Dermatomyositis Drug Sales by Application (2016-2021e) & (K Pcs)
Table 65. Global Dermatomyositis Drug Sales by Application (2021-2026) & (K Pcs)
Table 66. Global Dermatomyositis Drug Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Dermatomyositis Drug Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Dermatomyositis Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 69. Global Dermatomyositis Drug Price by Application (2021-2026) & (USD/Pcs)
Table 70. North America Dermatomyositis Drug Sales by Country (2016-2021e) & (K Pcs)
Table 71. North America Dermatomyositis Drug Sales by Country (2021-2026) & (K Pcs)
Table 72. North America Dermatomyositis Drug Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Dermatomyositis Drug Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Dermatomyositis Drug Sales by Type (2016-2021e) & (K Pcs)
Table 75. North America Dermatomyositis Drug Sales by Type (2021-2026) & (K Pcs)
Table 76. North America Dermatomyositis Drug Sales by Application (2016-2021e) & (K Pcs)
Table 77. North America Dermatomyositis Drug Sales by Application (2021-2026) & (K Pcs)
Table 78. Europe Dermatomyositis Drug Sales by Country (2016-2021e) & (K Pcs)
Table 79. Europe Dermatomyositis Drug Sales by Country (2021-2026) & (K Pcs)
Table 80. Europe Dermatomyositis Drug Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Dermatomyositis Drug Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Dermatomyositis Drug Sales by Type (2016-2021e) & (K Pcs)
Table 83. Europe Dermatomyositis Drug Sales by Type (2021-2026) & (K Pcs)
Table 84. Europe Dermatomyositis Drug Sales by Application (2016-2021e) & (K Pcs)
Table 85. Europe Dermatomyositis Drug Sales by Application (2021-2026) & (K Pcs)
Table 86. Asia-Pacific Dermatomyositis Drug Sales by Region (2016-2021e) & (K Pcs)
Table 87. Asia-Pacific Dermatomyositis Drug Sales by Region (2021-2026) & (K Pcs)
Table 88. Asia-Pacific Dermatomyositis Drug Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Dermatomyositis Drug Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Dermatomyositis Drug Sales by Type (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Dermatomyositis Drug Sales by Type (2021-2026) & (K Pcs)
Table 92. Asia-Pacific Dermatomyositis Drug Sales by Application (2016-2021e) & (K Pcs)
Table 93. Asia-Pacific Dermatomyositis Drug Sales by Application (2021-2026) & (K Pcs)
Table 94. South America Dermatomyositis Drug Sales by Country (2016-2021e) & (K Pcs)
Table 95. South America Dermatomyositis Drug Sales by Country (2021-2026) & (K Pcs)
Table 96. South America Dermatomyositis Drug Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Dermatomyositis Drug Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Dermatomyositis Drug Sales by Type (2016-2021e) & (K Pcs)
Table 99. South America Dermatomyositis Drug Sales by Type (2021-2026) & (K Pcs)
Table 100. South America Dermatomyositis Drug Sales by Application (2016-2021e) & (K Pcs)
Table 101. South America Dermatomyositis Drug Sales by Application (2021-2026) & (K Pcs)
Table 102. Middle East & Africa Dermatomyositis Drug Sales by Country (2016-2021e) & (K Pcs)
Table 103. Middle East & Africa Dermatomyositis Drug Sales by Country (2021-2026) & (K Pcs)
Table 104. Middle East & Africa Dermatomyositis Drug Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Dermatomyositis Drug Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Dermatomyositis Drug Sales by Type (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Dermatomyositis Drug Sales by Type (2021-2026) & (K Pcs)
Table 108. Middle East & Africa Dermatomyositis Drug Sales by Application (2016-2021e) & (K Pcs)
Table 109. Middle East & Africa Dermatomyositis Drug Sales by Application (2021-2026) & (K Pcs)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Dermatomyositis Drug Typical Distributors
Table 113. Dermatomyositis Drug Typical Customers
List of Figures
Figure 1. Dermatomyositis Drug Picture
Figure 2. Global Dermatomyositis Drug Sales Market Share by Type in 2020
Figure 3. Abatacept
Figure 4. Baricitinib
Figure 5. Dalazatide
Figure 6. Immune Globulin
Figure 7. IMO-8400
Figure 8. Others
Figure 9. Global Dermatomyositis Drug Sales Market Share by Application in 2020
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Dermatomyositis Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Dermatomyositis Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Dermatomyositis Drug Sales (2016-2026) & (K Pcs)
Figure 16. Global Dermatomyositis Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Dermatomyositis Drug Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Dermatomyositis Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Dermatomyositis Drug Market Drivers
Figure 20. Dermatomyositis Drug Market Restraints
Figure 21. Dermatomyositis Drug Market Trends
Figure 22. Global Dermatomyositis Drug Sales Market Share by Manufacturer in 2020
Figure 23. Global Dermatomyositis Drug Revenue Market Share by Manufacturer in 2020
Figure 24. Dermatomyositis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Dermatomyositis Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Dermatomyositis Drug Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Dermatomyositis Drug Sales Market Share by Region (2016-2026)
Figure 28. Global Dermatomyositis Drug Revenue Market Share by Region (2016-2026)
Figure 29. North America Dermatomyositis Drug Revenue (2016-2026) & (USD Million)
Figure 30. Europe Dermatomyositis Drug Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Dermatomyositis Drug Revenue (2016-2026) & (USD Million)
Figure 32. South America Dermatomyositis Drug Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Dermatomyositis Drug Revenue (2016-2026) & (USD Million)
Figure 34. Global Dermatomyositis Drug Sales Market Share by Type (2016-2026)
Figure 35. Global Dermatomyositis Drug Revenue Market Share by Type (2016-2026)
Figure 36. Global Dermatomyositis Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Dermatomyositis Drug Sales Market Share by Application (2016-2026)
Figure 38. Global Dermatomyositis Drug Revenue Market Share by Application (2016-2026)
Figure 39. Global Dermatomyositis Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Dermatomyositis Drug Sales Market Share by Type (2016-2026)
Figure 41. North America Dermatomyositis Drug Sales Market Share by Application (2016-2026)
Figure 42. North America Dermatomyositis Drug Sales Market Share by Country (2016-2026)
Figure 43. North America Dermatomyositis Drug Revenue Market Share by Country (2016-2026)
Figure 44. United States Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Dermatomyositis Drug Sales Market Share by Type (2016-2026)
Figure 48. Europe Dermatomyositis Drug Sales Market Share by Application (2016-2026)
Figure 49. Europe Dermatomyositis Drug Sales Market Share by Country (2016-2026)
Figure 50. Europe Dermatomyositis Drug Revenue Market Share by Country (2016-2026)
Figure 51. Germany Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Dermatomyositis Drug Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Dermatomyositis Drug Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Dermatomyositis Drug Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Dermatomyositis Drug Revenue Market Share by Region (2016-2026)
Figure 60. China Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Dermatomyositis Drug Sales Market Share by Type (2016-2026)
Figure 67. South America Dermatomyositis Drug Sales Market Share by Application (2016-2026)
Figure 68. South America Dermatomyositis Drug Sales Market Share by Country (2016-2026)
Figure 69. South America Dermatomyositis Drug Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Dermatomyositis Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Dermatomyositis Drug Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Dermatomyositis Drug Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Dermatomyositis Drug Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Dermatomyositis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の甲状腺機能低下症治療薬市場 2021：企業別、地域別、種類・用途別 The Hypothyroidism Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- オレンシア（アバタセプト）治療薬市場：世界及び中国市場分析・予測（～2024年） Orencia (abatacept) Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Orencia (abatacept) Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Orencia (abatacept) …
- 世界のゴセレリン薬市場 2021：企業別、地域別、種類・用途別 The Goserelin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の薬物乱用検査サービス市場 2021：企業別、地域別、種類・用途別 The Drug of Abuse Testing Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のバークホルデリア類鼻疽菌感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Burkholderia Pseudomallei Infections Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…